These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15546738)

  • 1. A comparative binding study of modified bovine immunodeficiency virus TAR RNA against its TAT peptide.
    Tok JB; Bi L; Huang S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6101-5. PubMed ID: 15546738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a cyclic peptide that targets a viral RNA.
    Runyon ST; Puglisi JD
    J Am Chem Soc; 2003 Dec; 125(51):15704-5. PubMed ID: 14677935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus.
    Athanassiou Z; Patora K; Dias RL; Moehle K; Robinson JA; Varani G
    Biochemistry; 2007 Jan; 46(3):741-51. PubMed ID: 17223695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics and solvation dynamics of BIV TAR RNA-Tat peptide interaction.
    Goel T; Kumar S; Maiti S
    Mol Biosyst; 2013 Jan; 9(1):88-98. PubMed ID: 23114563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of a dimeric RNA-peptide complex.
    Campisi DM; Calabro V; Frankel AD
    EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative binding study of BIV Tat peptide against its TAR RNA duplex, RNA-DNA heteroduplex and DNA duplex.
    Tok JB; Bi L
    Bioorg Med Chem Lett; 2005 Jan; 15(1):129-33. PubMed ID: 15582425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tethering of proteins to RNAs using the bovine immunodeficiency virus-Tat peptide and BIV-TAR RNA.
    Wakiyama M; Kaitsu Y; Muramatsu R; Takimoto K; Yokoyama S
    Anal Biochem; 2012 Aug; 427(2):130-2. PubMed ID: 22617800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility of BIV TAR-Tat: models of peptide binding.
    Hsieh M; Collins ED; Blomquist T; Lustig B
    J Biomol Struct Dyn; 2002 Oct; 20(2):243-51. PubMed ID: 12354076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics and binding specificity analysis of the bovine immunodeficiency virus BIV Tat-TAR complex.
    Reyes CM; Nifosì R; Frankel AD; Kollman PA
    Biophys J; 2001 Jun; 80(6):2833-42. PubMed ID: 11371457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific cross-linking of amino acids in the basic region of human immunodeficiency virus type 1 Tat peptide to chemically modified TAR RNA duplexes.
    Farrow MA; Aboul-ela F; Owen D; Karpeisky A; Beigelman L; Gait MJ
    Biochemistry; 1998 Mar; 37(9):3096-108. PubMed ID: 9485463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAR RNA recognition by a cyclic peptidomimetic of Tat protein.
    Leeper TC; Athanassiou Z; Dias RL; Robinson JA; Varani G
    Biochemistry; 2005 Sep; 44(37):12362-72. PubMed ID: 16156649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ; Metzger AU; Willbold D; Rösch P; Sticht H
    J Biomol Struct Dyn; 1998 Dec; 16(3):683-92. PubMed ID: 10052624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex.
    Puglisi JD; Chen L; Blanchard S; Frankel AD
    Science; 1995 Nov; 270(5239):1200-3. PubMed ID: 7502045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of a cyclic BIV beta-Tat peptide with its TAR RNA construct.
    Tok JB; Des Jean RC; Fenker J
    Bioorg Med Chem Lett; 2001 Jan; 11(1):43-6. PubMed ID: 11140729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X; Kumar RA; Patel DJ
    Chem Biol; 1995 Dec; 2(12):827-40. PubMed ID: 8807816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A docking and modelling strategy for peptide-RNA complexes: applications to BIV Tat-TAR and HIV Rev-RBE.
    Srinivasan J; Leclerc F; Xu W; Ellington AD; Cedergren R
    Fold Des; 1996; 1(6):463-72. PubMed ID: 9080192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.